Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2025-12-26 @ 4:17 AM
Study NCT ID:
NCT00593827
Status:
COMPLETED
Last Update Posted:
2016-03-10
First Post:
2008-01-04
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Sponsor:
R-Pharm
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-05
Start Date Type:
None
Primary Completion Date:
2010-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-08
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-04
First Submit QC Date:
None
Study First Post Date:
2008-01-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-03-14
Results First Submit QC Date:
None
Results First Post Date:
2012-05-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-02-09
Last Update Post Date:
2016-03-10
Last Update Post Date Type:
ESTIMATED